First Manhattan would not be buying more VVUS shares if they thought Qsymia would not be a blockbuster drug if it was managed in the right hands. They wouldn't bother trying to takeover the Board of Directors if they didn't think Qsymia could be partnered for a big investor profit. I think the last thing Eisai wants is to battle Qsymia with a BP marketing it. The move by First Manhattan will only speed up any partnership with Qsymia or buyout of VVUS. Much of the institutional shares were bought at $22.50 per share, so they would want more than that. Also one of the Board of Director nominees is David Norton formerly of Johnson and Johnson, isn't that coincidental..
I dont think partners matter here. What matters is Dr's identifying patents to try the drugs on. Drs can see with their eyes who needs these products. Don't need a patent watching TV ads to self identify as a potential user. Every Dr in the US knows about these new diet drugs. Will identified patents care enough to pay some real money for the shot at weight loss. That is the question.The rest is peripheral.
Actually they are taking over so they can protect their investment. They feel that if left to management they would lose their money, how can you spin this into something good? Your only hope is if they will modify the REMS and allow you a few more pharmacies. You have less then a 50/50 chance of that happening. Also don't forget the very costly and large on going studies required and oh ya, EU said no a second time.
I do not think you will get a marketing partnership since this can be sold generically at a much cheaper price. Nothing going on here folks move on....
Lets rehash this in 5 months.
VVUS is run by masters of spin/attorneys ....... the baggies left in the stock think they can spin as well ...... well if you count swirling in the toilet bowl as spinning they are doing quite well ...... Agree with you lukb.... they are after the board to save their backsides..... the company is toast on it's own as is the investment they and other institutions have made ....... still think it's a sinking ship.
Mookie, Mookie, Mookie,
To this point you have made the very wise decision to stay off of this board, or to make only infrequent and banal visits. You've made a simple post now and again, but we recognized you mostly as a non-combatant.
Are you certain that you want to take this step, especially at this stage of play? After all, the game is almost over.
I gotta tell ya Mookster, it doesn't make any sense.
We will come back at you. You will rue the day you chose to tread upon the toes of your betters. Go back to your board and play there.
There will not be another warning.
What a stupid post.
VVUS has not been able to obtain a BP partner in 7 months. What makes you think that they are going to get one now. It is not going to happen due to dismal sales, and don't forget about the pending law suits that will happen.
NO BP in their right mind would get into bed with VVUS, unless of course they have a death wish.
You have not been around long enough mooky as management of VVUS was looking for a partner with both there drugs before they even got the mediocre approval with REMS from the FDA. I guess what you are saying is these big funds that are not worried about loosing there investors money on VVUS, as they throw more at it. IF you were a big pharma would you go and buyout a company that took two generics and cut them in half and put them together and created one and with all the baggage that comes with the drug.
Sentiment: Strong Buy
You should not post here again Mook.
You don't have the internal fortitude to take the resulting criticism.
By that I mean that when we upset you you cry like a schoolgirl.
Then you run and tell.